Search for: "M. ROCHE" Results 21 - 40 of 288
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 May 2012, 7:41 am by Mi Patente
Por Roche Diferentes factores de riesgo han propiciado el incremento en la incidencia de este padecimiento  Diabetes, alcoholismo, tabaquismo, sedentarismo, obesidad, entre otros, se encuentran entre los principales factores para desarrollarlo El cáncer colorrectal ocupa el cuarto lugar de cáncer más común en el mundo. [read post]
24 May 2019, 3:30 am by Nora Freeman Engstrom
Allen Kachalia, Kenneth Sands, Melinda Van Niel, Suzanne Dodson, Stephanie Roche, Victor Novack, Maayan Yitshak-Sade, Patricia Folcarelli, Evan M. [read post]
16 Aug 2010, 4:28 am by Sean Wajert
Comic Dimitri Martin notes, "I'm sorry" and "I apologize" mean the same thing -- unless you are speaking to the widow at a funeral. [read post]
6 Dec 2017, 6:10 am
“It is absurd,” Olivier La Roche, a French-speaking Quebecer who runs the shop said, referring to the resolution. [read post]
23 Dec 2018, 6:38 pm
Anything that is slightly interesting, I'm out the door and in line. [read post]
20 Jan 2015, 1:36 pm by Ed. Microjuris.com Puerto Rico
Asimismo, éstos concedieron líneas de crédito con márgenes prestatarios mayor a lo establecido. [read post]
15 Jun 2011, 4:56 am by Marie Louise
(Patent Docs) Xeloda (Capecitabine) – US: Patent infringement complaint filed in response to Para IV certification: Hoffmann-La Roche Inc. v. [read post]
25 Jul 2019, 8:30 am by Dennis Crouch
  Genentech (Roche) has aggressively protected this multi-billion-dollar marketplace by asserting its patent rights against potential competitors. [read post]
13 Feb 2017, 8:52 am
Matti Niemivuo & Lotta Viikari, The Nordic Welfare State and the Development of Northern Finland Johnny Grøneng Aase & Julia Jabour, How Satellites Can Support the Information Requirements of the Polar Code Aileen M. [read post]
22 Jul 2011, 2:15 am
When it is M&A time, these issues certainly need to be highlighted as part of the IP due diligence report. [read post]
26 Dec 2017, 8:45 pm by Nate Nead
This article is one of a series outlining investment banking and M&A trends in diagnostics and in-vitro diagnostics. [read post]
4 Nov 2014, 3:45 am by Broc Romanek
In 2012, Illumina, a leading equipment maker in the nascent DNA sequencing market, faced a hostile tender offer from Roche Holding. [read post]
13 Feb 2018, 2:44 am by Nate Nead
This is evidenced by the strong activity in the M&A market from the industry’s largest players. [read post]